Deadline: 1-Apr-25
The Laerdal Foundation is pleased to announce the Saving Lives at Birth Program to provide financial support to practically oriented research to prevent needless deaths from sudden cardiac arrest, trauma, and during birth.
The Board will be prioritizing projects relating to interventions on day of birth – including prevention of stillborn deaths. Applications that go beyond a local impact and have the potential to document long term practical value and stimulate developments also in other regions/countries will be prioritized.
Funding Information
- The Board expects to fund up to 20 projects per year in this category, with a maximum amount of USD 50,000, with the average grant being around USD 30,000.
What they fund?
- The Foundation in particular welcomes applications that can advance treatment recommendations, education or implementation within:
- Resuscitation
- Trauma
- Maternal and/or newborn care
- 50 % is earmarked for projects or programs to save lives at birth in low-resource settings.
- They are also funding education research projects at, or in collaboration with the SAFER simulation center in Stavanger.
- Factors that can strengthen the chances of funding:
- High impact, including potential for scaling
- Synergies with other programs the Foundation is supporting
- Matching funding/multicenter collaborations
- Strong CV of principal investigator and mentor
Eligibility Criteria
- Applications are particularly welcome relating to:
- Innovative approaches to more efficient education and implementation
- Collaborative initiatives relating to scale-up of proven concepts
- Projects taking place in the Foundation’s focus countries: Tanzania, Ethiopia, Malawi, Bangladesh, India and Nepal.
What they do not fund?
- Applications with one or more of the following characteristics:
- No novelty – done before
- No hypothesis or weak methodology
- Ethically unacceptable or strongly questionable
- Only of local interest
- Relates solely to acquisition of equipment
- Building of hospitals or health centers
- Commercial interests
- Applications considered to have unrealistic budgets
- Congress participation, traveling support
- Vaccination, contamination microbiology
For more information, visit Laerdal Foundation.
